You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: aspirin does not reduce CV events but may reduce non-fatal stroke in peripheral artery disease

https://doi.org/10.1136/ebm.14.6.173

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Question

    In patients with peripheral artery disease (PAD), does aspirin reduce cardiovascular (CV) events?

    Review scope

    Included studies compared aspirin with placebo or control for reducing CV events in patients with PAD. Outcomes were a composite end point of non-fatal myocardial infarction (MI), non-fatal stroke, and CV mortality; individual components of the composite end point; all-cause …

    View Full Text

    Footnotes

    • Source of funding: National Heart, Lung, and Blood Institute.